![Abrasion-Resistant and Award-Winning: TEVA Relies on Schreiner MediPharm for Novel Adrenaline Injector Label | Packaging Connections Abrasion-Resistant and Award-Winning: TEVA Relies on Schreiner MediPharm for Novel Adrenaline Injector Label | Packaging Connections](https://www.packagingconnections.com/sites/default/files/SMP_Autoinjector-Label_Teva.jpg)
Abrasion-Resistant and Award-Winning: TEVA Relies on Schreiner MediPharm for Novel Adrenaline Injector Label | Packaging Connections
ANDA 077157 TEVA Pharmaceuticals USA Attention: Philip Erickson, R.Ph. Senior Director, Regulatory Affairs 1090 Horsham Road P.O
![Teva selects North Jersey site for its new North American headquarters. - Philadelphia Business Journal Teva selects North Jersey site for its new North American headquarters. - Philadelphia Business Journal](https://media.bizj.us/view/img/10278469/unknown-6*1200xx2016-1136-0-122.jpg)
Teva selects North Jersey site for its new North American headquarters. - Philadelphia Business Journal
![Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall of all Amlodipine/Valsartan Combination Tablets and Amlodipine/Valsartan/Hydrochlorothiazide Combination Tablets that are Within Expiry | FDA Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall of all Amlodipine/Valsartan Combination Tablets and Amlodipine/Valsartan/Hydrochlorothiazide Combination Tablets that are Within Expiry | FDA](https://www.fda.gov/files/styles/recall_image_small/public/8_0.jpg?itok=D_0TgstB)